Overview Cangrelor Prasugrel Transition Study Status: Completed Trial end date: 2013-07-01 Target enrollment: Participant gender: Summary To demonstrate that patients treated with cangrelor can be directly switched to oral prasugrel and that patients treated with prasugrel can be switched to cangrelor without a significant decrease in the extent of inhibition of platelet aggregation. Phase: Phase 2 Details Lead Sponsor: The Medicines CompanyTreatments: CangrelorPrasugrel Hydrochloride